or search on
|Title:||Lifestyle and reproductive risk factors associated with anal cancer in women aged over 50 years|
|Authors:||Coffey K; Beral V; Green J; Reeves G; Barnes I; for the Million Women Study Collaborators (incl. Canfell K)|
|Categories:||Cancer Type - Endometrial Cancer|
Cancer Type - Anal Cancer
Etiology - Interactions of Genes and/or Genetic Polymorphisms with Exogenous and/or Endogenous Factors
|Journal Title:||British Journal of Cancer|
|Page number start:||1568|
|Page number end:||1574|
|Abstract:||Abstract BACKGROUND: Anal cancer incidence increases with age and is higher in women than men. Risk factors in this group other than high-risk human papillomavirus infection are unclear. METHODS: In all, 1.3 million women were recruited in 1996-2001 and followed for incident anal cancer. Cox regression models were used to calculate relative risks (RRs) for anal cancer by various potential risk factors. RESULTS: Five hundred and seventeen incident anal cancers were registered over 13 years of follow-up. The largest RR was associated with a history of cervical intraepithelial neoplasia grade 3 (CIN 3; RR=4.03, 95% CI 2.59-6.28). Other factors associated with significantly increased risks in multivariate analyses were: ever smoking (RR=1.49, 1.24-1.80); previous use of oral contraceptives (RR=1.51, 1.24-1.83); nulliparity (RR=1.61, 1.24-2.07); tubal ligation (RR=1.39, 1.13-1.70) and not living with a partner (RR=1.82, 1.40-2.38). The association with smoking was significantly greater for squamous cell carcinoma than adenocarcinoma of the anus (RR 1.66 vs 0.89, P for heterogeneity=0.04). CONCLUSIONS: History of CIN 3, smoking, past oral contraceptive use, nulliparity, tubal ligation and not living with a partner are risk factors for anal cancer in women. There was a significant increase in risk associated with smoking for squamous cell anal cancers but not adenocarcinomas|
|Division:||Cancer Research Division|
|Funding Body:||The Million Women Study is funded by Cancer Research UK (grant no. C570/A16491) and the UK Medical Research Council (grant no. MR/K02700X/1). KC is supported by Cancer Research UK (CR-UK) grant number C38302/A12981, through an Oxford Cancer Research Centre Prize DPhil Studentship.|
|Appears in Collections:||Research Articles|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.